FDA Begins Reviews Under Continuous Marketing Application Pilot Program
Executive Summary
FDA has started reviewing two applications under its continuing marketing application "Pilot 1" program, Office of New Drugs Director John Jenkins, MD, reported at the World Health Care Congress Jan. 27 in Washington, D.C
You may also be interested in...
Second Continuous Marketing Application Pilot Program Is 44% Enrolled
Enrollment in FDA's second continuous marketing application pilot program is nearly 50% enrolled
Second Continuous Marketing Application Pilot Program Is 44% Enrolled
Enrollment in FDA's second continuous marketing application pilot program is nearly 50% enrolled
FDA Will Begin End-Of-Phase IIa Meetings Prior To January Guidance
FDA will begin a pilot program for end-of-Phase IIa meetings in advance of a draft guidance expected to be issued in early 2004